Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3164 Automatized hepatic tumor volume analysis of neuroendocrine liver metastases by Gd-EOB MRI - A deep learning model to support multidisciplinary cancer conference decision making

Introduction: Rapid quantification of liver metastasis for diagnosis and follow-up is an unmet medical need in patients with secondary liver malignancies.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Fehrenbach U

Authors: Fehrenbach U, Xin S, Hartenstein A, Auer T, Dräger F,

Keywords: liver metastases, automatised 3D quantification, deep learning, hepatic tumor load, response evaluation, MRI,

#2117 Neuroendocrine Tumors: An Australian Experience

Introduction: Neuroendocrine tumours (NETs) in Australia are rare, but are rising in incidence.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Ashoka Menon V, Reeders J, George M,

Keywords: retrospective, incidence, low to intermediate, neuroendocrine, australia,

#1724 Outcomes of Hepatobiliary Neuroendocrine Neoplasms Treated with Systemic Therapy: A Retrospective Analysis.

Introduction: Primary hepatobiliary neuroendocrine neoplasms (NEN) are rare. Knowledge about clinicopathological findings and treatment results of hepatobiliary NEN is limited.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Satoshi K, Chigusa M, Takuji O, Yasunari S, Shunsuke K,

Keywords: primary, hepatobiliary, neuroendocrine, neoplasms,

#608 Is Octreotide Benefitial in Patients with Metastatic Gastroenteropancreatic (GEP) and Hepatobiliary Neuroendocrine Carcinoma (NEC)?

Introduction: Neuroendocrine carcinomas (NECs) of the gastroenteropancreatic (GEP) and hepatobiliary (HB) tract are rare and a heterogenous group of malignancies. Octreotide showed the anti-tumor activity in well-differentiated metastatic midgut neuroendocrine tumors (NETs).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Kim S,

Keywords: NEC, octreotide, GEP, HB,